Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo surgery for obesity and reflux tested – but study stopped early

NCT ID NCT04626232

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 29 times

Summary

This study aimed to compare a standard sleeve gastrectomy (removing part of the stomach) with a modified version called N-Sleeve, which adds a wrap around the top of the stomach to prevent acid reflux. The trial was designed for people with severe obesity and GERD, but only 2 patients enrolled before the study was terminated. Because it stopped so early, we cannot draw any meaningful conclusions about which surgery might be better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY CANDIDATE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Montpellier

    Montpellier, 34295, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

surgical procedure (N-Sleeve: sleeve gastrectomy with Nissen fundoplication)

What this could lead to

If successful, the N-Sleeve technique could reduce acid reflux after weight-loss surgery, potentially improving quality of life for people with severe obesity and GERD.

What could go wrong

The trial was terminated early with only 2 participants, so no reliable conclusions can be drawn. The added procedure may also carry extra surgical risks.

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease morbid obesity Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.